Inactive Instrument

Acme Resources Corp Stock Toronto S.E.

Equities

ACYh

CA0047731074

Medical Equipment, Supplies & Distribution

End-of-day quote Toronto S.E.
- - Intraday chart for Acme Resources Corp
Sales 2022 1.75 0 Sales 2023 0.72 0 Capitalization 9.32M 0
Net income 2022 -8M - Net income 2023 -3M - EV / Sales 2022 15,898,275 x
Net Debt 2022 1.4M 0 Net Debt 2023 2.1M 0 EV / Sales 2023 15,894,851 x
P/E ratio 2022
-3.01 x
P/E ratio 2023
-2.44 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 90.12%
More Fundamentals * Assessed data
Rapid Dose Therapeutics Corp. announced that it expects to receive CAD 6 million in funding CI
Rapid Dose Therapeutics Corp. Appoints Angela O'Leary to the Board of Directors CI
Rapid Dose Therapeutics Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended November 30, 2023 CI
Rapid Dose Therapeutics Corp. announced that it expects to receive CAD 7 million in funding CI
Rapid Dose Therapeutics Corp. announced that it has received CAD 3.134445 million in funding CI
Rapid Dose Therapeutics Corp. Reports Earnings Results for the Second Quarter and Six Months Ended August 31, 2023 CI
Rapid Dose Therapeutics Corp. Announces the Resignation of Andrew Duckman from the Company's Board of Directors CI
Rapid Dose Therapeutics Corp. Reports Earnings Results for the First Quarter Ended May 28, 2023 CI
Rapid Dose Therapeutics Narrows Fiscal Q4 Loss, Revenue Grows MT
Rapid Dose Therapeutics Corp. Auditor Raises 'Going Concern' Doubt CI
Rapid Dose Therapeutics Corp. Reports Earnings Results for the Full Year Ended February 28, 2023 CI
Rapid Dose Increased Proposed Private Placement Financing of Up to $5 Million; Gained 30% on Tuesday MT
Rapid Dose Therapeutics Corp. announced that it expects to receive CAD 3 million in funding CI
Rapid Dose Therapeutics Corp. Launches QuickStrip™ Dental Products in the Canadian Market CI
Rapid Dose Therapeutics Corp. Announces Changes to Its Board of Directors CI
More news
Managers TitleAgeSince
Chief Executive Officer - 17-05-02
Director of Finance/CFO - 20-02-27
Corporate Officer/Principal - 19-01-22
Members of the board TitleAgeSince
General Counsel 77 19-12-05
Director/Board Member - 23-04-13
Director/Board Member - 20-08-12
More insiders
Rapid Dose Therapeutics Corp. is a Canadian biotechnology company. The Company provides disruptive drug delivery technologies designed to improve patient outcomes. The Company’s flagship product, QuickStrip, is a thin, orally dissolvable film that can be infused with an infinite list of active ingredients, including nutraceuticals, pharmaceuticals, and vaccines, that are delivered quickly into the bloodstream, resulting in rapid onset of the active ingredient. It offers over-the-counter and pharmaceutical drug delivery solutions. Its QuickStrip Energy delivers energizing caffeine. Its QuickStrip B12 delivers vitamin B12 to the system, assisting with metabolism and physical energy. Its QuickStrip Sleep delivers melatonin to the system, inducing natural and healthy sleep. QuickStrip Lidocaine is its dental product. The Company also provides production and consultation to the nutraceutical, cannabis healthcare and pharmaceutical manufacturing industries.
More about the company